You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Claims for Patent: 4,048,310


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,048,310
Title: Topical steroid formulation in form of lotion or cream
Abstract:Steroid formulations in the form of creams or lotions which are used as topical anti-inflammatory agents are provided wherein the steroid, such as 21-chloro-9.alpha.-fluoro-.DELTA..sup.4 -pregnene-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione 16,17-acetonide, is at least partially dissolved in a ricinoleate vehicle such as castor oil.
Inventor(s): Chen; James Ling (East Brunswick, NJ), Battaglia; Jean M. (North Brunswick, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:05/660,963
Patent Claims: 1. A composition for topical application in the form of a cream or lotion, comprising at least one steroid wherein said steroid is selected from the group consisting of 21-chloro-9.alpha.-fluoro-.DELTA..sup.4 -pregnene-11.beta., 16.alpha.,17.alpha.-triol-3,20-dione 16,17-acetonide; 21-chloro-9-fluoro-2',3'-dihydro-11.beta.-hydroxy-5'-propylpregna-1,4-dien o[16.alpha.,17-b][1,4]-dioxin-3,20-dione:dichloro methane solvate (1:1); and 9.alpha.-fluoro-11.beta., 16.alpha.,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione 16,17-acetonide, a ricinoleate vehicle in which said steroid is at least partially soluble, an emulsifier-thickener comprising a polyethylene glycol ether of a fatty alcohol, an oleaginous material or emollient, a preservative and water.

2. The composition as defined in claim 1 wherein said ricinoleate vehicle is castor oil.

3. The composition as defined in claim 1 wherein said steroid is present in an amount within the range of from about 0.005 to about 0.6% by weight of the composition said ricinoleate vehicle is present in an amount within the range of from about 0.5 to about 2% by weight of the composition, said emulsifier-thickener is present in an amount within the range of from about 1 to about 14% by weight of the composition, said oleaginous material or emollient is present in an amount within the range of from about 0.2 to about 8% by weight of the composition, said preservative is present in an amount within the range of from about 8 to about 50% by weight of the composition, and said water is present in an amount within the range of from about 30 to about 90% by weight water.

4. The composition as defined in claim 3 further including one or more antioxidants.

5. A composition as defined in claim 1 in the form of a cream wherein said steroid is all-in-solution, and said steroid is present in an amount within the range of from about 0.005 to about 0.6% by weight of the composition, said ricinoleate is present in an amount within the range of from about 0.5 to about 16% by weight of the composition, said emulsifier-thickener is present in an amount within the range of from about 5 to about 14% by weight of the composition, said oleaginous material or emollient is present in an amount within the range of from about 2 to about 8% by weight of the composition, said preservative is present in an amount within the range of from about 10 to about 50% by weight of the composition, and said water is present in an amount within the range of from about 30 to about 70% by weight of the compostion.

6. The composition as defined in claim 4 wherein said ricinoleate vehicle is castor oil.

7. A composition as defined in claim 1 in the form of a cream of the biphasic type, wherein said steroid is present in an amount within the range of from about 0.005 to about 0.6% by weight of the composition, said ricinoleate is present in an amount within the range of from about 0.5 to about 14% by weight of the composition, said emulsifier-thickener is present in an amount within the range of from about 8 to about 12% by weight of the composition, said oleaginous material or emollient is present in an amount within the range of from about 2 to about 8% by weight of the composition, said preservative is present in an amount within the range of from about 10 to about 50% by weight of the composition, and said water is present in an amount within the range of from about 30 to about 70% by weight of the composition.

8. The composition as defined in claim 7 wherein said ricinoleate vehicle is castor oil.

9. A composition as defined in claim 1 in the form of a lotion wherein said steroid is all-in-solution, said steroid is present in an amount within the range of from about 0.005 to about 0.6 % by weight of the composition, said ricinoleate is present in an amount within the range of from about 0.5 to about 16% by weight of the composition, said emulsifier-thickener is present in an amount within the range of from about 5 to about 14% by weight of the composition, aid oleaginous material or emollient is present in an amount within the range of from about 0.5 to about 6% by weight of the composition, said preservative is present in an amount within the range of from about 1 to about 50% by weight of the composition, and said water is present in an amount within the range of from about 50 to about 90% by weight of the compostion.

10. The composition as defined in claim 9 wherein said ricinoleate vehicle is castor oil.

11. A composition as defined in claim 1 in the form of a lotion of the biphasic type, wherein said steroid is present in an amount within the range of from about 0.005 to about 0.6% by weight of the composition, said ricinoleate is present in an amount within the range of from about 0.5 to about 14% by weight of the composition, said emulsifier-thickener is present in an amount within the range of from about 1 to about 5% by weight of the composition, said oleaginous material or emollient is present in an amount within the range of from about 0.2 to about 5% by weight of the composition, said preservative is present in an amount within the range of from about 8 to about 50% by weight of the composition, and said water is present in an amount within the range of from about 50 to about 90% by weight of the composition.

12. The composition as defined in claim 11 wherein said ricinoleate vehicle is castor oil.

13. A composition as defined in claim 1 wherein said steroid comprises 21-chloro-9.alpha.-fluoro-.DELTA..sup.4 -pregnene-11.beta., 16.alpha., 17.alpha.-triol-3,20-dione 16.17-acetonide.

14. A composition as defined in claim 1 wherein said steroid comprises 9.alpha.-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20 -dione 16.17-acetonide.

15. A composition as defined in claim 1 wherein aid oleaginous material is petrolatum, said emulsifier-thickener is polyethylene glycol fatty alcohol ether, and said preservative is propylene glycol.

16. A composition as defined in claim 1 further including econazole, nystatin, neomycin, gramicidin or mixtures thereof.

17. A composition as defined in claim 1 further including nystatin or econazole.

18. A composition as defined in claim 1 wherein said steroid comprises 21-chloro-9-fluoro-2',3'-dihydro-11.beta.-hydroxy-5'-phenylpregna-1,4-dien o[16.alpha.,17-b][1,4]dioxin-3,20-dione:dichloro methane solvate (1:1).

19. A method of treating dermatitis, which comprises administering topically an effecttive amount of a composition as defined in claim 1.

20. A method of treating dermatitis, which comprises administering topically an effective amount of a composition as defined in claim 3.

21. A method of treating dermatitis, which comprises administering topically an effective amount of a composition as defined in claim 5.

22. A method of treating dermatitis, which comprises administering topically an effective amount of a composition as defined in claim 7.

23. A method of treating dermatitis, which comprises administering topically an effective amount of a composition as defined in claim 9.

24. A method of treating dermatitis, which comprises administering topically an effective amount of a composition as defined in claim 11.

25. The composition as defined in claim 1 further including propylene glycol monostearate.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.